Metformin and Melatonin Treatment of Oral Premalignant Lesions

Enrolling By Invitation

99 years and younger

All

Phase N/A

36 participants needed

1 Location

Brief description of study

Please refer to section 1 of the protocol document Please refer to section 1 of the protocol document Please refer to section 1 of the protocol document

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: - 99 Years
Gender: All

TBD

Updated on 01 Aug 2024. Study ID: 853969

If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com